Vulvovaginitis and the treatment of asymptomatic partners: a systematic review and metanalisis
DST j. bras. doenças sex. transm
; 25(1)2013.
Article
in En
| LILACS
| ID: lil-696428
Responsible library:
BR408.4
ABSTRACT
Treating sexual partners of women with vaginal candidiasis and bacterial vaginosis is an issue in debate. Despite the present recommendations of the international guidelines to not to treat the asymptomatic sexual partners, this is a frequent practice between gynecologists. Objective:
evaluate the influence of treating asymptomatic sexual partner of women with recurrent vulvovaginitis.Methods:
databases searched PubMed, Embase, Scielo and CINAHAL. Selection criteria randomized clinical trials published from 1982 to 2012 were included. Studies involving pregnant women were excluded. Methodological quality was assessed using the Jadad scale. Data collection andanalysis:
Review Manager 5.1 was used for statistical analysis.Results:
eight randomized clinical trials were included based on the chosen criteria 1,088 women were enrolled. For bacterial vaginosis, the RR for cure was 1.00 (95%CI 0.95?1.05) (p = 0.13), and for recurrence 0.84 (95%CI 0.62-1.14) (p = 0.34). Vaginal candidiasis had a RR of 1.03 (95%CI 0.94-1.14) (p = 0.48) for cure, and 1.02 (95%CI 0.77?1.33 p = 0.91) for recurrence.Conclusion:
treatment of asymptomatic sexual partners of women with vaginal candidiasis or bacterial vaginosis does not affect the cure or recurrence rates and may increase the risk of side effects and unnecessary financial costs.Key words
Full text:
1
Index:
LILACS
Main subject:
Therapeutics
/
Vulvovaginitis
/
Candidiasis
/
Vaginosis, Bacterial
/
Spouses
Type of study:
Clinical_trials
/
Guideline
/
Systematic_reviews
Limits:
Adolescent
/
Female
/
Humans
Language:
En
Journal:
DST j. bras. doenças sex. transm
Journal subject:
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2013
Type:
Article